Alphatec Holdings, Inc. Provides Earnings Guidance for the Three Months Ended September 30, 2023
October 24, 2023 at 04:06 pm EDT
Share
Alphatec Holdings, Inc. provided earnings guidance for the three months ended September 30, 2023. For the period, the expects preliminary unaudited net loss of $43.2 million to $42.4 million, reflecting an expected increase in net loss of approximately $6.4 million to $5.6 million as compared to the three months ended September 30, 2022.
Alphatec Holdings, Inc., through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company. The Company is focused on the design, development, and advancement of technology for surgical treatment of spine disorders. It has a range of product portfolios designed to address the spine's various pathologies. Its AIX product platform comprises of its EOS imaging system and VEA alignment mobile application, its SafeOp Neural InformatiX System and Valence. The EOS imaging system is designed to provide calibrated full-body imaging that enables a three-dimensional (3D) model of patientsâ skeletal systems. It has developed a patient positioning systems that integrates with its other access systems, providing for a more rigid construct and enhanced reproducibility. It offers procedure-specific access systems, including its Sigma-ALIF Access System, which allows for custom anterior abdominal exposure.
ALPHATEC HOLDINGS, INC. 
